Table 2.

Participant enrollment and viral suppression at follow-up

A2C grantees	(a) Total participants served n	(b) Participants enrolled at least 1 year prior to the end of A2C n	All enrolled participants		Participants with data at both enrollment and 12 months
			(c) Virally suppressed at enrollment n (prop., 95% CI)	(d) Virally suppressed at 6 or 12 months n (prop., 95% CI)	(e) n	(f) Virally suppressed at enrollment n (prop., 95% CI)	(g) Virally suppressed at 12 months n (prop., 95% CI)	X2, p values
AIDS Action Committee	342	294	138 (0.40, 0.35–0.46)	237 (0.69, 0.64–0.74)	108	66 (0.61, 0.52–0.70)	90 (0.83, 0.75–0.89)	16.94, < 0.0001
AIDS Foundation Chicago	639	537	231 (0.36, 0.33–0.40)	333 (0.52, 0.48–0.56)	166	88 (0.53, 0.45–0.60)	113 (0.68, 0.60–0.75)	36.44, < 0.0010
Amida Care	833	797	438 (0.53, 0.49–0.56)	536 (0.64, 0.61–0.68)	441	291 (0.66, 0.61–0.70)	334 (0.76, 0.72–0.80)	17.61, < 0.0001
Christie’s Place	226	224	122 (0.54, 0.47–0.60)	137 (0.61, 0.54–0.67)	91	66 (0.73, 0.63–0.81)	77 (0.85, 0.76–0.91)	4.21, 0.0430
The Damien Center	149	134	16 (0.11, 0.07–0.17)	73 (0.49, 0.41–0.57)	51	10 (0.20, 0.11–0.32)	38 (0.75, 0.61–0.84)	4.26, < 0.0001
St. Louis Effort for AIDS	322	295	34 (0.11, 0.08–0.14)	210 (0.65, 0.60–0.70)	169	18 (0.11, 0.07–0.16)	128 (0.76, 0.69–0.82)	108.04, < 0.0001
Medical Advocacy and Outreach	244	244	189 (0.77, 0.72–0.82)	235 (0.96, 0.93–0.98)	185	148 (0.80, 0.74–0.85)	176 (0.95, 0.91–0.97)	15.26, < 0.0001

prop. proportion, 95% CI 95% confidence interval of the proportion

HIV infection averted or “A” = ((g − f)/e) * b/2